No abstract available
MeSH terms
-
Antibodies, Monoclonal / economics
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Anticholesteremic Agents / economics
-
Anticholesteremic Agents / therapeutic use*
-
Cardiovascular Diseases / blood
-
Cardiovascular Diseases / drug therapy*
-
Cardiovascular Diseases / economics
-
Cholesterol, LDL / blood
-
Cost-Benefit Analysis
-
Humans
-
Hypercholesterolemia / blood
-
Hypercholesterolemia / drug therapy*
-
Hypercholesterolemia / economics
-
Proprotein Convertase 9
-
Proprotein Convertases / antagonists & inhibitors*
-
Serine Endopeptidases
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Anticholesteremic Agents
-
Cholesterol, LDL
-
PCSK9 protein, human
-
Proprotein Convertase 9
-
Proprotein Convertases
-
Serine Endopeptidases
-
evolocumab
-
alirocumab